Anand Anandkumar

Dr. Anandkumar is the co-founder and CEO of Bugworks, an Indo/US/AUS company working on discovering highly differentiated therapies in Anti-Microbial Resistance (AMR) and Oncology indications. He is a serial entrepreneur in biotechnology and semiconductor domains. Before Bugworks, he was co-founder and MD at Cellworks, an Indo/US company that pioneered the use of systems biology and semiconductor technologies in creating personalised therapies in cancer care. Before Cellworks, Anand spent 18 years in the semiconductor industry, donning technical and global-executive roles in USA/EU/Japan/China and India. Anand is also a co-founder in Impres Healthcare, an incubator promoting innovation in biomedical sciences. He serves as a member of GARDP India advisory board, ex-member of the Board of AMR Industry Alliance, ex Vice President of the India Biotech Association and a founding member of the India Electronics and Semiconductor Association (IESA).